Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Charles Turck, PharmD, BCPS, BCCCP
Michael Javaheri, MD
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Brian P. McDonough, MD, FAAFP
Mitchell J. Goff
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
Insights and Updates: New Data on Next-Generation Retinal Treatments
Durga Borkar, MD, MMCi
Veeral Sheth, MD, MBA, FASRS, FACS
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Christina Y. Weng, MD, MBA, FASRS
Mark T. Dunbar, OD, FAAO
David A. Eichenbaum, MD, FAAO
Jaclyn Garlich, OD, FAAO
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
High Myopia and Visual Disability: New Evidence from a Spanish Clinical Cohort
Providing a Lifetime of Eye Health Care
Jessica O. Yu, OD, FAAO, FSLS
EMPOWER - Patient Communication: Building Trust and a Continuity of Care
Jacob Lang, OD, FAAO
Diana Chu, OD
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO
Contact Lenses Driving Business
Darryl Glover Jr., OD
Britt Gustafson, OD
Selina McGee, OD, FAAO
The Importance of Contact Lens Comfort
How Contact Lens Can Aid Patients' Digital Lifestyles
Jennifer Wademan, OD
Why Contact Lens Pricing Needs Simplicity
Aaron Neufeld, OD
Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Jeffrey Walline, OD, PhD
Biomarkers and Second-Generation Treatments
John W. Kitchens, MD
Sara LeMay, OD
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
John Kitchens, MD
How to Improve the Contact Lens Wearing Experience
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.